Cargando…

Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors

The Oxford classification for IgA nephropathy (IgAN) was updated in 2017. We have validated the revised Oxford classification considering treatment with corticosteroids/immunosuppressors. In this retrospective analysis, 871 IgAN patients were enrolled. Patients were divided into two groups, those tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moriyama, Takahito, Karasawa, Kazunori, Miyabe, Yoei, Akiyama, Kenichi, Ogura, Shota, Takabe, Tomo, Sugiura, Naoko, Seki, Momoko, Iwabuchi, Yuko, Uchida, Keiko, Nitta, Kosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341848/ https://www.ncbi.nlm.nih.gov/pubmed/32636449 http://dx.doi.org/10.1038/s41598-020-68087-y

Ejemplares similares

Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy
por: Miyabe, Yoei, et al.
Publicado: (2021)

A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy
por: Itami, Shusaku, et al.
Publicado: (2021)

Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin–angiotensin system inhibitors on its prognosis
por: Sugiura, Naoko, et al.
Publicado: (2021)

Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining
por: Karasawa, Kazunori, et al.
Publicado: (2019)

Analysis of Various Types of Glomerulonephritis with Crescents at a Single Center
por: Nakakita, Tomo, et al.
Publicado: (2022)

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018)

First case of a renal cyst infection caused by Desulfovibrio: a case report and literature review
por: Okamoto, Yoshiki, et al.
Publicado: (2022)

A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib
por: Karasawa, Kazunori, et al.
Publicado: (2023)

The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial
por: Moriyama, Takahito, et al.
Publicado: (2017)

Thymodepressin—Unforeseen Immunosuppressor
por: Deigin, Vladislav I., et al.
Publicado: (2021)

Rat Mesenchymal Stromal Cell Sheets Suppress Renal Fibrosis via Microvascular Protection
por: Imafuku, Aya, et al.
Publicado: (2019)

Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment
por: Iwabuchi, Yuko, et al.
Publicado: (2014)

A case of Lemierre syndrome combined with a suspected systemic lupus erythematosus flare
por: Fujii, Teruhiro, et al.
Publicado: (2019)

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R(2) Values in Relation to Renal Outcomes
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011)

Structural alterations in the seminiferous tubules of rats treated with immunosuppressor tacrolimus
por: Caneguim, Breno H, et al.
Publicado: (2009)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
por: Moriyama, Takahito, et al.
Publicado: (2014)

Optimal immunosuppressor induces stable gut microbiota after liver transplantation
por: Jiang, Jian-Wen, et al.
Publicado: (2018)

Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin
por: Lion, Julien, et al.
Publicado: (2017)

Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer
por: He, Zhong-Ning, et al.
Publicado: (2023)

SARS‐CoV‐2 and immunosuppressors at cellular level: Some good news
por: Abreu, Candida
Publicado: (2023)

Time series changes in pseudo-R(2) values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Prior Exposure to Immunosuppressors Sensitizes Retinal Microglia and Accelerates Optic Nerve Regeneration in Zebrafish
por: Bollaerts, Ilse, et al.
Publicado: (2019)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Reduction in flippase activity contributes to surface presentation of phosphatidylserine in human senescent erythrocytes
por: Seki, Momoko, et al.
Publicado: (2020)

IgA nephropathy and kidney transplantation according to the Oxford classification
por: Vasconcelos, André de Sá, et al.
Publicado: (2023)

Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
por: Hirano, Keita, et al.
Publicado: (2015)

Three cases of late-onset oligomeganephronia
por: Kawanishi, Kunio, et al.
Publicado: (2011)

Validation Study of the Oxford Classification for IgA Nephropathy in Korean Adults
por: Choi, Bum Soon
Publicado: (2012)

Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis
por: Pardo, Evelyn, et al.
Publicado: (2017)

IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report
por: Watanabe, Shota, et al.
Publicado: (2022)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Central fibrous areas: changes in glomerular vascular pole lesions associated with age and disease
por: Kanetsuna, Yukiko, et al.
Publicado: (2022)

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
por: Coppo, Rosanna, et al.
Publicado: (2014)

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
por: Le, Weibo, et al.
Publicado: (2012)

Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy
por: Xu, Lin-Lin, et al.
Publicado: (2023)

Reproducibility of Oxford Scoring in IgA Nephropathy: Is the Noise Due to an Educational Gap?
por: Herlitz, Leal C.
Publicado: (2023)

Systematic Review of the Oxford Classification of IgA Nephropathy: Reproducibility and Prognostic Value
por: Howie, Alexander J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lve56uj8mvshlj7mli30gm4f7u